Press releases

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics

GSK and Orchard Therapeutics today announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard, securing the continued development of the programmes and access for patients

Read more

Orchard Therapeutics Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer and General Counsel

Orchard Therapeutics announces two key additions to its executive leadership team, appointing Jason Meyenburg as chief commercial officer and John Ilett as general counsel & company secretary

Read more

Orchard Therapeutics Scientific Founder Prof Donald Kohn Recognized with Pediatric Blood and Marrow Transplant Consortium Lifetime Achievement Award

Orchard Therapeutics Scientific Founder Prof Donald Kohn Recognized with Pediatric Blood and Marrow Transplant Consortium Lifetime Achievement Award

Read more

Orchard Therapeutics to Present at the Cowen and Company Annual Healthcare Conference

Orchard Therapeutics today announced that Mark Rothera, president and chief executive officer, will present at the Cowen & Co. 38th Annual Healthcare Conference

Read more

Orchard Therapeutics Appoints Dr. Harry Malech to Scientific Advisory Board

Orchard Therapeutics today announced the appointment of Harry Malech, M.D., to its scientific advisory board

Read more